 |
| |
BLOSSOM:
Behavioral Modification and Lorcaserin Second Study for Obesity Management
A 52-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients
The MGH Weight Center is now enrolling for a new clinical trial for the treatment of obesity!
The study will run for 64 weeks. Study related exams and drug as well as periodic nutritional counseling will be provided free of charge for those who qualify. Remuneration of up to $700 will also be provided.
The study will consist of:
- taking a study drug or placebo (sugar pill - no active medicine or drug ) for 1 year. If you take part in this study, you may not get the study drug
- individual nutritional counseling
- monthly visits to the MGH Weight Center to meet with the study team and dietitian
Eligible subjects must:
- be between the ages of 18 and 65
- not have diabetes
- be overweight
- willing and able to commit to the study and taking the medication (or placebo) for 1 year
If you are interested in participating in this study, please review the complete description of the study including potential benefits and risks of this study. We are seeking subjects that will be committed to the study and the lifestyle program for the full 1-year time period.
I am interested in this study. I would like to find out if I am eligible >>
 |
Contact Us |
 |
|
 |
Become a Patient |
 |
Events Apply: Research: For people who are overweight |
